<DOC>
	<DOCNO>NCT00518089</DOCNO>
	<brief_summary>The study determine safety efficacy gatifloxacin eye drop patient bacterial conjunctivitis</brief_summary>
	<brief_title>A Study Safety Efficacy Gatifloxacin Patients With Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Clinically diagnose bacterial conjunctivitis Signs and/or symptom conjunctivitis 96 hour Signs and/or symptom suggestive fungal , viral , allergic conjunctivitis Clinical diagnosis chlamydia either eye</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>